CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 198 filers reported holding CONMED CORP in Q2 2018. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $10,381,000 | +23.8% | 163,924 | -0.4% | 2.52% | -3.7% |
| Q4 2017 | $8,387,000 | -16.6% | 164,547 | -14.1% | 2.61% | -16.6% |
| Q3 2017 | $10,053,000 | -12.9% | 191,601 | -15.4% | 3.13% | -10.5% |
| Q2 2017 | $11,538,000 | -27.1% | 226,497 | -36.4% | 3.50% | -31.4% |
| Q1 2017 | $15,823,000 | +9.0% | 356,304 | +8.4% | 5.10% | -2.0% |
| Q4 2016 | $14,518,000 | +11.2% | 328,677 | +0.9% | 5.20% | +10.4% |
| Q3 2016 | $13,051,000 | -16.9% | 325,785 | -1.0% | 4.72% | -16.7% |
| Q2 2016 | $15,710,000 | +14.4% | 329,142 | +0.5% | 5.66% | +14.9% |
| Q1 2016 | $13,734,000 | -5.2% | 327,460 | -0.5% | 4.93% | +6.6% |
| Q4 2015 | $14,493,000 | +10.6% | 329,011 | +19.8% | 4.62% | -2.5% |
| Q3 2015 | $13,106,000 | -15.3% | 274,528 | +3.4% | 4.74% | -18.7% |
| Q2 2015 | $15,466,000 | +21.9% | 265,428 | +5.6% | 5.83% | +1.0% |
| Q1 2015 | $12,687,000 | +9.3% | 251,274 | -2.7% | 5.78% | -10.6% |
| Q4 2014 | $11,605,000 | – | 258,117 | – | 6.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 27,500 | $2,437,600 | 2.23% |
| Ranger Investment Management | 316,318 | $28,038,428 | 2.08% |
| Lighthouse Investment Partners, LLC | 142,100 | $12,595,744 | 1.39% |
| Lighthouse Investment Partners, LLC | 139,200 | $12,338,688 | 1.36% |
| EARNEST PARTNERS LLC | 2,402,352 | $212,944,481 | 1.30% |
| Lighthouse Investment Partners, LLC | 108,200 | $9,590,848 | 1.06% |
| MOODY ALDRICH PARTNERS LLC | 51,885 | $4,599,086 | 0.93% |
| MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID | 125,435 | $11,118,558 | 0.81% |
| Champlain Investment Partners, LLC | 1,275,910 | $113,096,662 | 0.72% |
| EPIQ PARTNERS, LLC | 10,463 | $927,440 | 0.62% |